Drugs / rHA0
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00328107 | Nov 2004 → Aug 2005 | influenza | Protein Sciences Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rHA0 | “an experimental trivalent influenza virus hemagglutinin (rHA0) vaccine produced in insect cells using recombinant baculoviruses” PMID 17426277 ↗ Apr 2007 |
| Modality | Vaccine | “an experimental trivalent influenza virus hemagglutinin (rHA0) vaccine produced in insect cells using recombinant baculoviruses” PMID 17426277 ↗ Apr 2007 |
| Route | Intramuscular | “Administered Intramuscularly” NCT00328107 ↗ |